He Huang
2 clinical trials · 2 recruiting · OTHER
Trials by He Huang
RECRUITINGPhase 1NCT06084962
A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma
Clinical Trial for the safety and efficacy of DeepTag-GPRC5D targeted CAR-T cells therapy for refractory/relapsed multiple myeloma
Sponsor: He HuangEnrolling: 401 location
Relapse/Refractory Multiple Myeloma
RECRUITINGNCT06162338
A Study of the Safety and Preliminary Efficacy of LY-M001 Injection in the Treatment of Adult Patients with Gaucher...
This is a prospective single-center, open, single-arm, single-dose intravenous infusion study to evaluate the safety and initial efficacy, pharmacodynamic characteristics,...
Sponsor: He HuangEnrolling: 31 location
Gaucher Disease Type I